Biotech · Private company · Palo Alto, CA, US
Innovation Pathways, LLC
Track this companyFree. Adds Innovation Pathways, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- The pharmacological development of IPW-5371 fumarate as a radiation medical countermeasure for the treatment of delayed radiation lung injury under the FDA animal ruleFiscal year 2026 · $109.2KNIH RePORTER 75N93023C00014-P00008-9999-1 · fetched Nov 12, 2026
- THE PHARMACOLOGICAL DEVELOPMENT OF IPW-5371 FUMARATE AS A RADIATION MEDICAL COUNTERMEASURE FOR THE TREATMENT OF DELAYED RADIATION LUNG INJURY UNDER THE FDA ANIMAL RULEFiscal year 2025 · $499.9KNIH RePORTER 75N93023C00014-P00005-9999-1 · fetched Nov 12, 2026
- THE PHARMACOLOGICAL DEVELOPMENT OF IPW-5371 FUMARATE AS A RADIATION MEDICAL COUNTERMEASURE FOR THE TREATMENT OF DELAYED RADIATION LUNG INJURY UNDER THE FDA ANIMAL RULEFiscal year 2024 · $1.5MNIH RePORTER 75N93023C00014-P00003-9999-1 · fetched Nov 12, 2026